XYNOMIC PHARMACEUTICALS HOLDINGS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $62.91 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2019-05-14
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-03-31 was $62.91K, a 71.42% increase year-over-year.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-12-31 was $60.80K, a 151.57% increase year-over-year.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-09-30 was $9.76K, a 59.18% decline year-over-year.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-06-30 was -$21.03K.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $86.22K, a 9.60% increase from fiscal 2017.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $78.67K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2019-03-31 | $62.91K 10-Q · filed 2019-05-14 | $123.71K derived: sum of 2 quarters · filed 2019-05-14 | $133.47K derived: sum of 3 quarters · filed 2019-05-14 | $112.43K derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | $60.80K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $70.56K derived: sum of 2 quarters · filed 2019-03-05 | $49.53K derived: sum of 3 quarters · filed 2019-03-05 | $86.22K 10-K · filed 2019-03-05 |
| 2018-09-30 | $9.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$11.28K derived: sum of 2 quarters · filed 2018-11-13 | $25.42K 10-Q · filed 2018-11-13 | $49.59K derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-06-30 | -$21.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $15.66K 10-Q · filed 2018-08-07 | $39.83K derived: sum of 3 quarters · filed 2019-05-14 | $63.74K derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-03-31 | $36.70K 10-Q · filed 2019-05-14 | $60.87K derived: sum of 2 quarters · filed 2019-05-14 | $84.77K derived: sum of 3 quarters · filed 2019-05-14 | |
| 2017-12-31 | $24.17K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $48.07K derived: sum of 2 quarters · filed 2019-03-05 | $78.67K 10-K · filed 2019-03-05 | |
| 2017-09-30 | $23.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $54.50K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $30.60K 10-Q · filed 2018-08-07 |